A new molecular imaging agent can accurately identify a crucial biomarker found among many different types of cancer.

The FDA has approved cosibelimab (marketed under the brand name Unloxcyt), a new drug for adults with advanced cutaneous squamous cell carcinoma (CSCC), a type of skin cancer.

Courtney Mangan was 29 when she was given a slim chance of survival after receiving a shock skin cancer diagnosis ...

The following is a summary of “How dermatologic surgeons decide to proceed with surgery for nonmelanoma skin cancer when site ...

A 32-year-old Australian woman’s seemingly harmless pimple on the forehead was eventually diagnosed as skin cancer when it failed to heal in two years. According to Rachel Olivia, she was told by ...

Skin cancers are the most common cancer worldwide,1 and early diagnosis is associated with better outcomes.2 There is ...

LMU researchers have discovered how the interplay between a key protein and an endolysosomal ion channel promotes tumor ...

Researchers have discovered how the interplay between a key protein and an endolysosomal ion channel promotes tumor development in skin cancer. LMU researchers have discovered how the interplay ...

LMU researchers have discovered how the interplay between a key protein and an endolysosomal ion channel promotes tumor development in skin cancer. A team led by LMU pharmacologist Professor ...

A team of researchers at Clemson University used an innovative multiomics approach to identify key immune mechanisms in a chronic and debilitating inflammatory skin condition. The research ...